|
|
|
|
|
|||||||
|
Session 88
Poster Session
GBV-C Co-Infection 4:30-6:30 pm 4E-F |
to view the poster for an abstract.| 666-M. | Effect of Co-Infection by Hepatitis C Virus (HCV) and GB-Virus C (HGV) on CD4 and HIV RNA among HIV-Infected Patients Treated by HAART N. Voirin*1,2, C. Trépo3, J. Estève1, P. Chevallier2, J. Ritter2, and P. Vanhems2 1Lyon-Sud Hosp.; 2Claude Bernard Univ.; and 3INSERM Unit 271, Lyon, France
| ||
| 667-M. | Slower Progression of HIV-1 Infection in HGV Co-Infected Individuals Correlates with an Intact T-Helper-1 Cytokine Profile G. Nunnari*1, 2, L. Nigro1, F. Palermo2, A. Berger3, H. W. Doerr, R. Russo, R. J. Pomerantz2, and B. Cacopardo1 1Univ. of Catania, Italy; 2Thomas Jefferson Univ., Philadelphia, PA; and 3Johann Wolfgang Goethe Univ., Frankfurt/Main, Germany
| ||
| 668-M. | Different GB Virus C Replication Phenotypes Present in Individuals Co-Infected with HIV and GBV-C S. L. George* and J. T. Stapleton Iowa City VA Med. Ctr. and Univ. of Iowa
| ||
| 669-M. | GB Virus C NS5A Protein: Sequence Variation in the Putative Interferon Sensitivity Determining Region (ISDR) in HIV-Positive and HIV-Negative Individuals J. Xiang*, Q. Chang, S. L. George, and J. Stapleton Iowa City VA Med. Ctr. and Univ. of Iowa
| ||
| 670-M. | Reduced Mortality in HIV-1-Infected Patients with GBV-C Viremia Is not Associated with Chemokine Receptor Mutations H. Heiken*, H. L. Tillmann, M. Stoll, M. P. Manns, and R. E. Schmidt Hannover Med. Sch., Germany
| ||
| 671-M. | Prevalence of HIV and GBV-C Virus Co-Infection and the Likelihood of HIV Genotypic Resistance Development M. Kozal*1, G. Friedland1, J. Chiarella1, T. Kyriakides1, J. Concato1, D. Klinzman2, and J. Stapleton2 1Yale Univ. Sch. of Med., New Haven, CT and VA of Connecticut Healthcare System and 2Univ. of Iowa, Iowa City
|
